These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 29123100)

  • 1. DNA methylation at enhancers identifies distinct breast cancer lineages.
    Fleischer T; Tekpli X; Mathelier A; Wang S; Nebdal D; Dhakal HP; Sahlberg KK; Schlichting E; ; Børresen-Dale AL; Borgen E; Naume B; Eskeland R; Frigessi A; Tost J; Hurtado A; Kristensen VN
    Nat Commun; 2017 Nov; 8(1):1379. PubMed ID: 29123100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperativity of co-factor NR2F2 with Pioneer Factors GATA3, FOXA1 in promoting ERα function.
    Jiang G; Wang X; Sheng D; Zhou L; Liu Y; Xu C; Liu S; Zhang J
    Theranostics; 2019; 9(22):6501-6516. PubMed ID: 31588232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NR2F2 Orphan Nuclear Receptor is Involved in Estrogen Receptor Alpha-Mediated Transcriptional Regulation in Luminal A Breast Cancer Cells.
    Erdős E; Bálint BL
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32168782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer.
    Aure MR; Fleischer T; Bjørklund S; Ankill J; Castro-Mondragon JA; ; Børresen-Dale AL; Tost J; Sahlberg KK; Mathelier A; Tekpli X; Kristensen VN
    Genome Med; 2021 Apr; 13(1):72. PubMed ID: 33926515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inferring regulatory element landscapes and transcription factor networks from cancer methylomes.
    Yao L; Shen H; Laird PW; Farnham PJ; Berman BP
    Genome Biol; 2015 May; 16(1):105. PubMed ID: 25994056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
    Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
    Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonlinear relationship between chromatin accessibility and estradiol-regulated gene expression.
    Chen D; Parker TM; Bhat-Nakshatri P; Chu X; Liu Y; Wang Y; Nakshatri H
    Oncogene; 2021 Feb; 40(7):1332-1346. PubMed ID: 33420376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
    Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
    Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of estrogen receptor α binding on functional DNA methylation in breast cancer.
    Ung M; Ma X; Johnson KC; Christensen BC; Cheng C
    Epigenetics; 2014 Apr; 9(4):523-32. PubMed ID: 24434785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha.
    Frietze S; O'Geen H; Littlepage LE; Simion C; Sweeney CA; Farnham PJ; Krig SR
    BMC Genomics; 2014 Jun; 15(1):520. PubMed ID: 24962896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3.
    Jozwik KM; Chernukhin I; Serandour AA; Nagarajan S; Carroll JS
    Cell Rep; 2016 Dec; 17(10):2715-2723. PubMed ID: 27926873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
    Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
    Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
    [No Abstract]   [Full Text] [Related]  

  • 13. A transcriptional complex composed of ER(α), GATA3, FOXA1 and ELL3 regulates IL-20 expression in breast cancer cells.
    Lee JY; Park YJ; Oh N; Kwack KB; Park KS
    Oncotarget; 2017 Jun; 8(26):42752-42760. PubMed ID: 28514748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXA1 in breast cancer.
    Nakshatri H; Badve S
    Expert Rev Mol Med; 2009 Mar; 11():e8. PubMed ID: 19261198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enrichment of CpG island shore region hypermethylation in epigenetic breast field cancerization.
    Muse ME; Titus AJ; Salas LA; Wilkins OM; Mullen C; Gregory KJ; Schneider SS; Crisi GM; Jawale RM; Otis CN; Christensen BC; Arcaro KF
    Epigenetics; 2020 Oct; 15(10):1093-1106. PubMed ID: 32255732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast tumor specific mutation in GATA3 affects physiological mechanisms regulating transcription factor turnover.
    Adomas AB; Grimm SA; Malone C; Takaku M; Sims JK; Wade PA
    BMC Cancer; 2014 Apr; 14():278. PubMed ID: 24758297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variations of DNA bindings of FOXA1 and co-factors in breast cancer susceptibility.
    Wen W; Chen Z; Bao J; Long Q; Shu XO; Zheng W; Guo X
    Nat Commun; 2021 Sep; 12(1):5318. PubMed ID: 34518541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the epigenetic profile of ID4 in breast cancer: bioinformatic insights into methylation patterns and chromatin accessibility dynamics.
    Nasif D; Laurito S; Real S; Branham MT
    Breast Cancer Res Treat; 2024 Aug; 207(1):91-101. PubMed ID: 38702584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNFα signaling exposes latent estrogen receptor binding sites to alter the breast cancer cell transcriptome.
    Franco HL; Nagari A; Kraus WL
    Mol Cell; 2015 Apr; 58(1):21-34. PubMed ID: 25752574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TET2 is a component of the estrogen receptor complex and controls 5mC to 5hmC conversion at estrogen receptor cis-regulatory regions.
    Broome R; Chernukhin I; Jamieson S; Kishore K; Papachristou EK; Mao SQ; Tejedo CG; Mahtey A; Theodorou V; Groen AJ; D'Santos C; Balasubramanian S; Farcas AM; Siersbæk R; Carroll JS
    Cell Rep; 2021 Feb; 34(8):108776. PubMed ID: 33626359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.